Nutex Health, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

267.80

243.99

211.79

257.62

78.79

76.08

67.45

Other Operating Income

0.00

Total Operating income

267.80

243.99

211.79

257.62

78.79

76.08

67.45

Raw Material Cost

112.92

119.06

93.45

115.99

56.88

53.52

57.30

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

5.45

5.68

6.12

5.05

5.38

5.05

4.44

Selling and Distribution Expenses

24.51

91.25

37.68

27.35

11.83

10.59

8.71

Other Expenses

-0.55

-0.57

-0.61

-0.51

-0.54

-0.51

-0.44

Total Expenditure (Excl Depreciation)

137.44

210.31

131.13

143.34

68.71

64.11

66.00

Operating Profit (PBDIT) excl Other Income

130.39999999999998

33.7

80.7

114.3

10.1

1.4000000000000001

Other Income

-0.98

-4.27

-3.33

-0.04

-0.13

0.60

0.24

Operating Profit (PBDIT)

134.39

34.66

82.43

119.51

14.93

17.10

5.88

Interest

5.45

5.68

6.12

5.05

5.38

5.05

4.44

Exceptional Items

0.00

-0.52

-7.16

-3.61

2.60

Gross Profit (PBDT)

154.88

124.92

118.34

141.63

21.92

22.56

10.16

Depreciation

5.00

5.25

5.09

5.28

4.97

4.53

4.19

Profit Before Tax

123.94

23.73

71.22

108.65

-2.58

3.90

-0.15

Tax

27.14

7.59

20.41

9.15

4.58

0.89

0.39

Provisions and contingencies

0.00

Profit After Tax

55.44

-17.70

21.22

61.61

-8.79

-0.36

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

55.44

-17.70

21.22

61.61

-8.79

-0.36

Share in Profit of Associates

0.00

Minority Interest

41.36

33.84

29.59

37.89

1.62

3.37

-0.18

Other related items

0.00

Consolidated Net Profit

96.80

16.14

50.81

99.50

-7.17

3.01

-0.54

Equity Capital

0.00

Face Value

0.0

Reserves

317.17

235.25

176.95

132.44

60.44

62.73

63.02

Earnings per share (EPS)

7.76

-2.95

3.29

11.18

-1.72

-0.05

-0.07

Diluted Earnings per share

7.76

-2.95

3.29

11.18

-1.72

-0.05

-0.07

Operating Profit Margin (Excl OI)

48.68%

13.8%

38.09%

44.36%

12.8%

15.73%

2.15%

Gross Profit Margin

48.15%

11.88%

36.03%

44.23%

3.04%

11.09%

5.98%

PAT Margin

20.7%

-7.25%

10.02%

23.92%

-11.15%

-0.48%

-0.54%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 9.75% vs 15.20% in Jun 2025

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 501.24% vs -68.31% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 248.07% vs -54.66% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -3.51% vs -6.56% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Nutex Health, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

267.80

6.77

261.03

3,855.69%

Other Operating Income

0.00

Total Operating income

267.80

6.77

261.03

3,855.69%

Raw Material Cost

112.92

4.20

108.72

2,588.57%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

5.45

0.01

5.44

54,400.00%

Selling and Distribution Expenses

24.51

2.63

21.88

831.94%

Other Expenses

-0.55

-0.00

-0.55

Total Expenditure (Excl Depreciation)

137.44

6.83

130.61

1,912.30%

Operating Profit (PBDIT) excl Other Income

130.37

-0.06

130.43

217,383.33%

Other Income

-0.98

-0.01

-0.97

-9,700.00%

Operating Profit (PBDIT)

134.39

0.37

134.02

36,221.62%

Interest

5.45

0.01

5.44

54,400.00%

Exceptional Items

0.00

Gross Profit (PBDT)

154.88

2.57

152.31

5,926.46%

Depreciation

5.00

0.44

4.56

1,036.36%

Profit Before Tax

123.94

-0.08

124.02

155,025.00%

Tax

27.14

0.00

27.14

Provisions and contingencies

0.00

Profit After Tax

55.44

-0.08

55.52

69,400.00%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

55.44

-0.08

55.52

69,400.00%

Share in Profit of Associates

0.00

Minority Interest

41.36

0.00

41.36

Other related items

0.00

Consolidated Net Profit

96.80

-0.08

96.88

121,100.00%

Equity Capital

0.00

Face Value

0.00

0.01

0.00

Reserves

317.17

13.75

303.42

2,206.69%

Earnings per share (EPS)

7.76

-0.05

7.81

15,620.00%

Diluted Earnings per share

7.76

-0.05

7.81

15,620.00%

Operating Profit Margin (Excl OI)

48.68%

-0.90%

0.00

49.58%

Gross Profit Margin

48.15%

5.29%

0.00

42.86%

PAT Margin

20.70%

-1.17%

0.00

21.87%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 26.78 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 9.75% vs 15.20% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 239.85% vs 25.68% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 9.68 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 501.24% vs -68.31% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 1,444.44% vs -60.00% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 13.54 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 248.07% vs -54.66% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 796.69% vs 277.50% in Sep 2024

Quarterly - Interest

Interest 0.55 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -3.51% vs -6.56% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 1.85% vs 31.71% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 48.68%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024